Success will be data driven From our chairman 16th Nov 18 “ 2019...

Success will be data driven

From our chairman 16th Nov 18
“ 2019 will be a crucial year for our Company as we prepare to report the first Progression Free Survival (PFS) data from the AIPAC trial. This PFS data in 2019 represents a major milestone for Immutep”


From our CEO . Jan 2019


“The Immutep team is very encouraged by the clinical data reported in 2018. The scene is set for a very data heavy 2019 that will support our business development efforts, also a key area for 2019. We look forward to reporting final or interim read-outs of all our studies in 2019.”


The ducks are lining up and for months now, management have been dropping little positive hints and snippets about this year’s data - so to the traders...don’t get caught with your pants down

After years and years of waiting I get the feeling we are about to see the birth of a giant success story here and for us long term investors, our long term faith and support of this company may soon be rewarded.
GLTA